Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(33 sites) United States
Research Network Arizona, Scottsdale, Arizona Global Research Management, Inc., Glendale, California UCLA Stein Eye Institute, Los Angeles, California Stanford Byers Eye Institute, Palo Alto, California California Eye Specialists Medical Group, Inc., Pasadena, California California Eye Specialists Medical Group, Inc., Redlands, California Retina Consultants of Southern California, Redlands, California Retinal Consultants Medical Group Inc, Sacramento, California Retina Group of New England, PC, Waterford, Connecticut Retina Group of Florida (Ft. Lauderdale), Fort Lauderdale, Florida Associated Vitreoretinal and Uveitis Consultants LLC, Carmel, Indiana Cumberland Valley Retina Consultants, Hagerstown, Maryland Retina Consultants of Minnesota, Saint Louis Park, Minnesota The Retina Institute, St Louis, Missouri Retina Associates of New York, P.C., New York, New York North Carolina Retina Associates (Cary), Cary, North Carolina North Carolina Retina Associates (Wake Forest), Wake Forest, North Carolina Cascade Medical Research Institute, Springfield, Oregon Erie Retina Research, Erie, Pennsylvania Charleston Neuroscience Institute, LLC (Charleston), Charleston, South Carolina Palmetto Retina Center (West Columbia), West Columbia, South Carolina Vanderbilt Eye Institute, Nashville, Tennessee Austin Retina Associates, PLLC (Austin), Austin, Texas Retina Consultants of Texas (Bellaire), Bellaire, Texas Texas Retina Center, Houston, Texas Retina Consultants of Texas (Katy), Katy, Texas Texas Retina Associates (Plano), Plano, Texas Austin Retina Associates, PLLC (Round Rock), Round Rock, Texas Retina Consultants of Texas (San Antonio), San Antonio, Texas Retina Consultants of Texas (Woodlands), The Woodlands, Texas Pacific Northwest Retina (Bellevue), Bellevue, Washington Pacific Northwest Retina (Silverdale), Silverdale, Washington